InflaRx (IFRX) Stock Price, Quote, News & History | Benzinga

InflaRx NV (IFRX) Stock Price, Quote, News & History

IFRXNASDAQ

Trade with Public

Trade with Public

$2.42

-0.04-1.63%

At close: Aug 26, 5:00 PM EST

$2.42

0.00320.13%

After Hours: 6:52 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$2.45

Close

$2.42

Volume / Avg.

1.71M / 1.16M

Day Range

$2.33 - $2.50

52 Wk Range

0.80 - 2.95

Market Cap

$356.92M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

7.01%

Days to Cover

9.5

Recent InflaRx NV News

InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway

InflaRx outlines restructuring plans, workforce cuts, and reduced Gohibic spending to extend cash runway and focus development efforts on izicopan through mid-2027.

Vandana Singh

InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder

InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.

Vandana Singh

Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Biogen's Immunology Pipeline Has Long-Term Potential: Analyst

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases.

Vandana Singh

Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.

Vishaal Sanjay

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-23.71M

Investing Cash Flow (TTM)

29.48M

Financing Cash Flow (TTM)

125.63M

Free Cash Flow (TTM)

-23.85M

Capital Expenditure (TTM)

-135.94K

Net Change in Cash (TTM)

131.39M

Analyst Trends and Forecast

1

Mar

1

Apr

3

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$177.07M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.11

Earnings Yield % (TTM)

-23.84%

Earnings Yield % (FWD)

-12.78%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.16

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$309.21K

Total Cash

$146.57M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$309.21K

Repayment of Debt (TTM)

-$309.21K

Key Statistics

Open

$2.45

Close

$2.42

Volume / Avg.

1.71M / 1.16M

Day Range

$2.33 - $2.50

52 Wk Range

0.80 - 2.95

Market Cap

$356.92M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

7.01%

Days to Cover

9.5

About

Sector

Health Care

Industry

Biotechnology

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product can...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy InflaRx (IFRX) stock?

A

You can purchase shares of InflaRx (NASDAQ:IFRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are InflaRx (IFRX) competitors?

A

Other companies in InflaRx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for InflaRx (IFRX) stock?

A

InflaRx has a consensus price target of $8.78.

Q

What is the current price for InflaRx (IFRX)?

A

The stock price for InflaRx (NASDAQ: IFRX) is $2.4232 last updated August 26, 2026 at 6:52 PM EDT.

Q

Does InflaRx (IFRX) pay a dividend?

A

There are no upcoming dividends for InflaRx.

Q

When is InflaRx (NASDAQ:IFRX) reporting earnings?

A

InflaRx does not have any upcoming earnings scheduled.

Q

Is InflaRx (IFRX) going to split?

A

There is no upcoming split for InflaRx.

Q

What sector and industry does InflaRx (IFRX) operate in?

A

InflaRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.